Technical Analysis for CRL - Charles River Laboratories Intl

Grade Last Price % Change Price Change
A 357.78 1.38% 4.8600
CRL closed up 1.38 percent on Thursday, June 17, 2021, on 72 percent of normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Up
Historical CRL trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Expansion Breakout Bullish Swing Setup 0.00%
New 52 Week High Strength 0.00%
Overbought Stochastic Strength 0.00%
Slingshot Bullish Bullish Swing Setup 1.38%
Overbought Stochastic Strength 1.38%
Narrow Range Bar Range Contraction 0.97%
NR7 Range Contraction 0.97%
New 52 Week High Strength 0.97%
Upper Bollinger Band Walk Strength 0.97%
Older End-of-Day Signals for CRL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Slingshot Bullish Entry about 9 hours ago
Rose Above Previous Day's High about 9 hours ago
Up 1% about 9 hours ago
New 52 Week High about 9 hours ago
Fell Below Previous Day's Low 1 day ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Charles River Laboratories Intl Description

Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily purpose-bred rats and mice for use by researchers. It also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification of a druggable target through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as bioanalysis, drug metabolism, pharmacokinetics, safety pharmacology, toxicology, and pathology services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile biopharmaceuticals, and consumer products. It also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Pharmaceutical Industry Biopharmaceutical Life Sciences Pharmacy Consumer Products Pharmacology Drug Discovery Vaccines Metabolism Diagnostic Products Vivo Archer Biopharmaceuticals Diagnostic Product Pharmaceutical And Biotech Pathology Diagnostic Services Ggs Pharmaceutical And Biotechnology Biotechnology Companies Kinetics Manufacturing Segment Contract Research Organizations Toxicology Pharmacokinetics Assessment Services Drug Metabolism Safety Testing Services Bioanalysis Pathology Services

Is CRL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 359.555
52 Week Low 177.45
Average Volume 556,942
200-Day Moving Average 0.0000
50-Day Moving Average 329.3194
20-Day Moving Average 338.4900
10-Day Moving Average 347.9060
Average True Range 7.3719
ADX 28.95
+DI 31.6592
-DI 14.3159
Chandelier Exit (Long, 3 ATRs) 337.4393
Chandelier Exit (Short, 3 ATRs) 335.2157
Upper Bollinger Bands 362.0067
Lower Bollinger Band 314.9733
Percent B (%b) 0.91
BandWidth 13.8951
MACD Line 8.4150
MACD Signal Line 6.6671
MACD Histogram 1.7479
Fundamentals Value
Market Cap 17.8 Billion
Num Shares 49.7 Million
EPS 6.00
Price-to-Earnings (P/E) Ratio 59.66
Price-to-Sales 4.03
Price-to-Book 5.94
PEG Ratio 1.70
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 371.5275
Resistance 3 (R3) 370.5917 365.0733 369.2363
Resistance 2 (R2) 365.0733 361.5723 365.5413 368.4719
Resistance 1 (R1) 361.4267 359.4094 363.2500 362.3625 367.7084
Pivot Point 355.9083 355.9083 356.8200 356.3763 355.9083
Support 1 (S1) 352.2617 352.4073 354.0850 353.1975 347.8516
Support 2 (S2) 346.7433 350.2444 347.2113 347.0881
Support 3 (S3) 343.0967 346.7433 346.3238
Support 4 (S4) 344.0325